EP2644204
Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.3.2009EP published:
19.4.2017EP application number:
13158391.6
EPO information:
European Patent Register
Max expiry date:
9.3.2029
Title:
Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab
Timeline
Today
10.3.2009EP application
19.4.2017EP Publication
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, 94080, South San Francisco, CA, US
Inventor
Name:
Berry, LeanneAddress:
South San Francisco, CA California, US
Name:
Phillips, Gail, LewisAddress:
San Carlos, CA California, US
Name:
Sliwkowski Mark, X.Address:
San Carlos, CA California, US
Priority
Number:
37410 PDate:
18.3.2008Country:
US
Classification
Categories:
A61K 39/395, A61K 47/50, A61K 45/06, A61P 35/00